LGR4 and colorectal cancer: In colorectal cancer, LGR4 overexpression upregulates the ferroptosis inhibitor SLC7A11 via Wnt-dependent mechanisms, fostering chemoresistance, while LGR4 blockade induces lipid peroxidation to restore drug sensitivity [20].